1:00 PM - 1:10 PM
-
Opening Remarks
Monday, March 29 1:00 PM - 1:10 PM
Speaker
Welcome and Overview of Sessions
1:10 PM - 2:15 PM
-
Part 1: National Context and Intelligence Overview
Monday, March 29 1:10 PM - 2:15 PM
Speaker
Overview of National Methamphetamine Strategy
Overview of the Precursor Control Regulations and federal law enforcement working group on precursors
Intelligence update on the current methamphetamine and precursor chemical environment
2:15 PM - 3:00 PM
-
Part 2: Technical Applications in Operational Settings
Monday, March 29 2:15 PM - 3:00 PM
Speaker
Clandestine labs, production and trafficking
3:00 PM - 3:15 PM
3:15 PM - 4:00 PM
-
Part 3: Community and Public Safety Impacts
Monday, March 29 3:15 PM - 4:00 PM
Speaker
Discussion of patient centered approaches; clinical approach to injectable opioid agonist therapy (iOAT) and to prescribing dextroamphetamine; and findings from qualitative research on patient perceptions of dextroamphetamine.
4:00 PM - 4:30 PM
-
Part 4: Reflections and Next Steps
Monday, March 29 4:00 PM - 4:30 PM
Identification of priority areas for future action